UPDATE: Magnolia Medical files another suit against Kurin

Updated to include a response from Kurin. Magnolia Medical Technologies said yesterday that it filed another legal action against blood-culture-focused device developer Kurin, this time claiming the company has infringed on patents related to its Steripath technology. The Seattle-based company asserts that Kurin is infringing upon four patents related to its Steripath blood collection technology with its Kurin Lock product. Magnolia Medical said that the “four patents represent and cover years of Magnolia’s research and development,” and added that it plans to “vigorously defend its technology.” The company said that it is seeking damages and a permanent injunction barring the production, use and selling of the Kurin Lock device. “Magnolia uses its technology to decrease patient risk by reducing misdiagnosis and mistreatment of sepsis, which also strongly supports antibiotic stewardship. Dr. Richard Patton and I have spent more than a decade developing unique medical innovations that deliver scientifically proven results, and we are committed to making sure Steripath and its future are appropriately protected, ensuring that patients and hospitals will benefit from Magnolia’s technology,” CEO Greg Bullington said in a press release. Kurin responded to Magnolia by claiming that the allegations the company raised were false and accusing Magnolia of “mismanagement.” “Magnolia’s unusual tactic to email blast the...
Source: Mass Device - Category: Medical Devices Authors: Tags: Blood Management Legal News Patent Infringement kurin Magnolia Medical Technologies Source Type: news